Sangamo Therapeutics, Inc. (SGMOQ)
OTCMKTS · Delayed Price · Currency is USD
0.14778
+0.00768 (5.48%)
At close: Oct 9, 2026
Sangamo Therapeutics Employees
Sangamo Therapeutics had 142 employees as of December 31, 2025. The number of employees decreased by 41 or -22.40% compared to the previous year. That makes Sangamo Therapeutics the 29,228th largest employer in the world and 3,715th in the United States.
Employees
142
Change (1Y)
-41
Growth (1Y)
-22.40%
Revenue / Employee
$243,359
Profits / Employee
-$868,521
Market Cap
61.22M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 142 | -41 | -22.40% |
| Dec 31, 2024 | 183 | -222 | -54.81% |
| Dec 31, 2023 | 405 | -73 | -15.27% |
| Dec 31, 2022 | 478 | 47 | 10.90% |
| Dec 31, 2021 | 431 | 18 | 4.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Vaxart | 65 |
| Nuo Therapeutics | 10 |
| Provectus Biopharmaceuticals | 6 |
| Vicapsys Life Sciences | 2 |
| Cell Source | 1 |
Sangamo Therapeutics News
- 1 month ago - Sangamo Therapeutics Selects Successful Bidders Following Competitive Asset Auction for $163.55 Million in Cash Consideration at Closing and Up to $100 Million in Potential Milestones - GlobeNewsWire
- 3 months ago - Sangamo Therapeutics Enters Into Asset Sale Agreements with Lilly and Astellas - GlobeNewsWire
- 4 months ago - Sangamo Therapeutics Announces Exploration of Strategic Alternatives to Maximize Value for Stakeholders - GlobeNewsWire
- 4 months ago - Sangamo Therapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 4 months ago - Sangamo Therapeutics Quarterly report: Q1 2026 - Filings
- 4 months ago - Sangamo Therapeutics Earnings release: Q1 2026 - Filings
- 4 months ago - Sangamo Therapeutics Slides: Q1 2026 - Filings
- 4 months ago - Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2026 Financial Results - GlobeNewsWire